Progress in the Discovery of Macrocyclic Histone Deacetylase Inhibitors for the Treatment of Cancer

Publisher： Bentham Science Publishers

E-ISSN： 1875-533x|24|37|4166-4179

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.24, Iss.37, 2017-12, pp. : 4166-4179

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Macrocyclic Histone Deacetylase Inhibitors

By  

Current Topics in Medicinal Chemistry, Vol. 10, Iss. 14, 2010-10 ,pp. : 1423-1440

Bentham Science Publishers

Access to resources Recommend Favorite

Histone Deacetylase Inhibitors for the Treatment of Colorectal Cancer: Recent Progress and Future Prospects

By  

Current Cancer Drug Targets, Vol. 17, Iss. 5, 2017-05 ,pp. : 456-466

Bentham Science Publishers

Access to resources Recommend Favorite

Recent Progress in the Development of Histone Deacetylase Inhibitors as Anti-Cancer Agents

By  

Mini Reviews in Medicinal Chemistry, Vol. 13, Iss. 14, 2013-12 ,pp. : 1999-2013

Bentham Science Publishers

Access to resources Recommend Favorite

An Epigenetic Approach to Pancreatic Cancer Treatment: The Prospective Role of Histone Deacetylase Inhibitors

By  

Current Cancer Drug Targets, Vol. 12, Iss. 4, 2012-04 ,pp. : 439-452

Bentham Science Publishers

Access to resources Recommend Favorite

Histone deacetylase inhibitors: discovery and development as anticancer agents

By Marks Paul A   Dokmanovic Milos  

Expert Opinion on Investigational Drugs, Vol. 14, Iss. 12, 2005-12 ,pp. : 1497-1511

Informa Healthcare

Access to resources Recommend Favorite